1. Home
  2. CRS vs ASND Comparison

CRS vs ASND Comparison

Compare CRS & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carpenter Technology Corporation

CRS

Carpenter Technology Corporation

HOLD

Current Price

$338.24

Market Cap

15.4B

Sector

Industrials

ML Signal

HOLD

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$212.55

Market Cap

12.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRS
ASND
Founded
1910
2006
Country
United States
Denmark
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.4B
12.8B
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
CRS
ASND
Price
$338.24
$212.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
15
Target Price
$374.60
$256.40
AVG Volume (30 Days)
983.1K
700.6K
Earning Date
01-29-2026
02-11-2026
Dividend Yield
0.24%
N/A
EPS Growth
82.03
N/A
EPS
8.18
N/A
Revenue
$2,893,200,000.00
$758,592,045.00
Revenue This Year
$7.30
$98.90
Revenue Next Year
$8.97
$83.74
P/E Ratio
$41.05
N/A
Revenue Growth
2.40
97.46
52 Week Low
$138.61
$118.03
52 Week High
$344.99
$229.94

Technical Indicators

Market Signals
Indicator
CRS
ASND
Relative Strength Index (RSI) 59.89 53.38
Support Level $329.17 $204.50
Resistance Level $344.99 $215.98
Average True Range (ATR) 10.28 7.45
MACD 0.72 0.25
Stochastic Oscillator 77.76 67.58

Price Performance

Historical Comparison
CRS
ASND

About CRS Carpenter Technology Corporation

Carpenter Technology Corp supplies specialty metals to a variety of end markets, including aerospace and defense, industrial machinery and consumer durables, medical, and energy, among others. The company's reportable segments include; Specialty Alloys Operations and Performance Engineered Products. It generates maximum revenue from the Specialty Alloys Operations segment. The SAO segment is comprised of the company's alloy and stainless steel manufacturing operations. This includes operations performed at mills predominantly in Reading and Latrobe, Pennsylvania, and surrounding areas as well as South Carolina and Alabama. Geographically, the company derives its maximum revenue from the United States and the rest from Europe, Asia Pacific, Mexico, Canada, and other regions.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.

Share on Social Networks: